½ÃÀ庸°í¼­
»óǰÄÚµå
1698355

¼¼°èÀÇ Ç÷°ü Á¢±Ù ½Ã½ºÅÛ ½ÃÀå ¿¹Ãø(2025-2030³â)

Global Vascular Access Systems Market - Forecasts from 2025 to 2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Knowledge Sourcing Intelligence | ÆäÀÌÁö Á¤º¸: ¿µ¹® 149 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°èÀÇ Ç÷°ü Á¢±Ù ½Ã½ºÅÛ ½ÃÀåÀº 2025³âºÎÅÍ 2030³â±îÁö ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR) 6.5%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

Á¤¸Æ ¶Ç´Â µ¿¸Æ¿¡ ´ëÇÑ Á¢±ÙÀº Ç÷°ü Á¢±Ù ½Ã½ºÅÛ¿¡ ÀÇÇØ ¾ò¾îÁý´Ï´Ù. Ç÷°ü Á¢±Ù ÀåÄ¡ ¹× ½Ã½ºÅÛÀº ÀǾàǰ °ø±Þ, ÁÖÀÔ ¹× ¿µ¾ç ¼ººÐ Åõ¿©, Ç÷°ü ¹× ±× Á¦Ç°ÀÇ È¸¼ö¸¦ À§ÇØ Ç÷·ù¿¡ Á¢±ÙÇÏ´Â µ¥ »ç¿ëµÇ´Â ÀÇ·á±â±âÀÔ´Ï´Ù. ÀÌ Ç÷°ü Á¢±Ù Æ©ºê´Â ¶óÅØ½º, ½Ç¸®ÄÜ ¹× ±âŸ ¹°Áú·Î ¸¸µé¾îÁý´Ï´Ù. ÀÌ ÀýÂ÷¿¡¼­´Â Áø´Ü °Ë»ç¿Í È­Çпä¹ý, Ç×»ýÁ¦ÀÇ Á¤¸Æ³» Åõ¿©, Á¤¸Æ¿µ¾ç µîÀÇ Ä¡·á¸¦ ½Ç½ÃÇϱâ À§ÇØ °æÁú ÇÃ¶ó½ºÆ½ Æ©ºê¸¦ ¹ÙÁú Á¤¸ÆÀ̳ª ¼â°ñÇÏ Á¤¸Æ µîÀÇ Ç÷°ü¿¡ À¯Ä¡ÇÕ´Ï´Ù. äÇ÷, ¼öÇ÷, ¼ö¾×, Á᫐ Á¤¸Æ¾Ð ÃøÁ¤ µîµµ Æ÷ÇԵ˴ϴÙ. Ç÷°ü Á¢±Ù Ä«Å×ÅÍ ±â±¸´Â È­ÇÐ ¿ä¹ýÀÇ °æ¿ì¿¡µµ ¸¹ÀÌ »ç¿ëµË´Ï´Ù.

½ÃÀå µ¿Çâ :

  • Ç÷°ü Á¢±Ù ÀåÄ¡¸¦ ÅëÇÑ Áö¼ÓÀûÀÎ Ç÷¾× Àü´Þ : Ç÷¾×Àº ij´¼¶ó, Ä«Å×ÅÍ, ÁÖº¯ ÀåÄ¡, Æ÷Æ® µî°ú °°Àº Ç÷°ü Á¢±Ù ÀåÄ¡¸¦ »ç¿ëÇÏ¿© Àå±â°£¿¡ °ÉÃÄ »ç¶÷ÀÇ Ç÷·ù·Î ¶Ç´Â Ç÷·ù¿¡¼­ À̼۵˴ϴÙ. ÀÌ ¹æ¹ýÀº ¿©·¯ ¹ø ¹Ù´ÃÀ» Â Çʿ䰡 ¾ø±â ¶§¹®¿¡ Ç÷¾× äÃë¿Í º¹¿ë Áß¿¡ ½ºÆ®·¹½º¿Í °íÅëÀÌ Àû½À´Ï´Ù. ½ÅºÎÀü, ´ç´¢º´, ¾Ï µî, ¼öÇ÷À» ÇÊ¿ä·Î ÇÏ´Â ÁúȯÀÇ ¼¼°èÀÇ ¸¸¿¬ÀÌ, Ç÷°ü Á¢±Ù ½Ã½ºÅÛ¿¡ ´ëÇÑ ¼ö¿ä¸¦ °ßÀÎÇϰí ÀÖ½À´Ï´Ù. ±×·¯³ª ³ôÀº °¨¿° À§Çè°ú Á¤ºÎÀÇ ¾ö°ÝÇÑ ½ÂÀÎ ÇÁ·Î¼¼½º¿Í °°Àº °úÁ¦´Â ½ÃÀå ¼ºÀåÀ» Á¦ÇÑÇϰí ÀÖ½À´Ï´Ù.
  • ½ÃÀå ¼ö¿ä¸¦ ÃËÁøÇÏ´Â ¿äÀÎ : ´ç´¢º´ÀÇ ÀÌȯÀ² »ó½Â, ±³Åë»ç°í Áõ°¡, ¼ö¼ú¼öÁõ µîÀÌ Ç÷°ü Á¢±Ù ÀåÄ¡ ¼ö¿ä¸¦ ²ø¾î¿Ã¸± °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ, ¹«Ä§ ¾à¹° Åõ¿©¿Í °°Àº ÷´Ü ±â¼ú·ÎÀÇ À̵¿Àº ÀÌ·¯ÇÑ ÀåºñÀÇ Ã¤ÅÃÀ» ´õ¿í °¡¼ÓÈ­Çϰí ÀÖ½À´Ï´Ù.
  • Á¾ÇÕÀûÀÎ ½ÃÀå ºÐ¼® : Ç÷°ü Á¢±Ù ½Ã½ºÅÛ ½ÃÀå º¸°í¼­´Â ¾÷°èÀÇ »ó¼¼ÇÑ ºÐ¼®À» Á¦°øÇÏ°í µ¥ÀÌÅÍ Áß½ÉÀÇ ¿¹ÃøÀ» µÞ¹ÞħÇÏ´Â Àü·«Àû ¹× ÁÖ¿ä ¼öÁØÀÇ ÅëÂû·ÂÀ» Á¦°øÇÕ´Ï´Ù. Á¤±âÀûÀ¸·Î ¾÷µ¥ÀÌÆ®µÇ´Â º¸°í¼­´Â ÀÇ»ç °áÁ¤ÀÚ¿¡°Ô ÇöÀç ½ÃÀå µ¿Çâ, »õ·Î¿î ºñÁî´Ï½º ±âȸ ¹× ½ÃÀå °æÀï·Â¿¡ ´ëÇÑ ½Ç¿ëÀûÀÎ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù. ¸»ÃÊ »ðÀÔÇü Á᫐ Á¤¸Æ Ä«Å×ÅÍ(PICC), ºñÅͳÎÇü Á᫐ Á¤¸Æ Ä«Å×ÅÍ, ÅͳÎÇü Ä«Å×ÅÍ, Æ÷Æ® Ä«Å×ÅÍ µî ´Ù¾çÇÑ Ç÷°ü Á¢±Ù Á¦Ç°¿¡ ´ëÇÑ ¼ö¿ä¸¦ Áö¿ªº°·Î ºÐ¼®Çß½À´Ï´Ù. ¶ÇÇÑ ÁÖ¿ä Á¤ºÎ Á¤Ã¥, ±ÔÁ¦ ¹× Á¤Ã¥, °Å½Ã °æÁ¦ ¿äÀΰú ÇÔ²² ¿¬°á Ç÷°ü Á¢±Ù ½Ã½ºÅÛÀÇ Ãֽбâ¼ú Áøº¸µµ Æò°¡ÇÏ¿© ½ÃÀåÀÇ Àü¹ÝÀûÀÎ ¸ð½ÀÀ» º¸¿©ÁÝ´Ï´Ù.

ÀÌ º¸°í¼­¿¡¼­ ´Ù·ç´Â ÁÖ¿ä ±â¾÷À¸·Î´Â Edwards Lifesciences Corporation, Baxter International Inc., Fresenius Medical Care AG & Co. KGaA, Becton, Dickinson and Company, Teleflex Incorporated, Medtronic PLC, B. Braun Melsungen AG, ICU Medical, Biomerics LLC µîÀÌ ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­ÀÇ ÁÖ¿ä ÀÌÁ¡

  • ÅëÂû·Â ÀÖ´Â ºÐ¼® : °í°´ ºÎ¹®, Á¤ºÎ Á¤Ã¥ ¹× »çȸ°æÁ¦ ¿äÀÎ, ¼ÒºñÀÚ ¼±È£, »ê¾÷º° ¹× ±âŸ ºÎ¹® ºÎ¹®¿¡ ÃÊÁ¡À» ¸ÂÃß¾î ÁÖ¿ä Áö¿ª»Ó¸¸ ¾Æ´Ï¶ó ½ÅÈï Áö¿ªµµ ´Ù·ç´Â »ó¼¼ÇÑ ½ÃÀå °í·Á»çÇ×À» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.
  • °æÀï ±¸µµ : ¼¼°è ÁÖ¿ä ±â¾÷ÀÌ Ã¤ÅÃÇÑ Àü·«À» ÀÌÇØÇϰí ÀûÀýÇÑ Àü·«À¸·Î ½ÃÀå ħÅõ °¡´É¼ºÀ» ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.
  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀΰú ¹Ì·¡ µ¿Çâ : ¿ªµ¿ÀûÀÎ ¿äÀΰú ¸Å¿ì Áß¿äÇÑ ½ÃÀå µ¿Çâ, ±×¸®°í ±×°ÍÀÌ ÇâÈÄ ½ÃÀå Àü°³¸¦ ¾î¶»°Ô Çü¼ºÇØ ³ª°¥Áö ޱ¸ÇÕ´Ï´Ù.
  • Çൿ °¡´ÉÇÑ Á¦¾È : ¿ªµ¿ÀûÀΠȯ°æ¿¡¼­ »õ·Î¿î ºñÁî´Ï½º ½ºÆ®¸²°ú ¼öÀÍÀ» ¹ß±¼Çϱâ À§ÇÑ Àü·«Àû ÀÇ»ç°áÁ¤¿¡ ÅëÂû·ÂÀ» Ȱ¿ëÇÕ´Ï´Ù.
  • Æø³ÐÀº ÀÌ¿ëÀÚ¿¡ ´ëÀÀ : ½ÅÈï±â¾÷, ¿¬±¸±â°ü, ÄÁ¼³ÅÏÆ®, Áß¼Ò±â¾÷, ´ë±â¾÷¿¡ À¯ÀÍÇÏ°í ºñ¿ë È¿À²ÀûÀÔ´Ï´Ù.

¾î¶² ¿ëµµ·Î »ç¿ëµË´Ï±î?

¾÷°è ¹× ½ÃÀå ÀλçÀÌÆ®, »ç¾÷ ±âȸ Æò°¡, Á¦Ç° ¼ö¿ä ¿¹Ãø, ½ÃÀå ÁøÃâ Àü·«, Áö¸®Àû È®´ë, ¼³ºñ ÅõÀÚ °áÁ¤, ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©¿Í ¿µÇâ, ½ÅÁ¦Ç° °³¹ß, °æÀïÀÇ ¿µÇâ

ºÐ¼® ¹üÀ§

  • °ú°Å µ¥ÀÌÅÍ(2022-2024³â)¿Í ¿¹Ãø µ¥ÀÌÅÍ(2025-2030³â)
  • ¼ºÀå ±âȸ, °úÁ¦, °ø±Þ¸Á Àü¸Á, ±ÔÁ¦ Ʋ, °í°´ Çൿ, µ¿Ç⠺м®
  • °æÀï ±â¾÷ÀÇ Æ÷Áö¼Å´×, Àü·«, ½ÃÀå Á¡À¯À² ºÐ¼®
  • ¼öÀÍ ¼ºÀå·ü°ú ¿¹Ãø ºÐ¼® : ºÎ¹®º°, Áö¿ªº°(±¹°¡º°)
  • ±â¾÷ ÇÁ·ÎÆÄÀϸµ(Àü·«, Á¦Ç°, À繫 Á¤º¸, ÁÖ¿ä µ¿Çâ µî)

Ç÷°ü Á¢±Ù ½Ã½ºÅÛ ½ÃÀå ³»¿ª

Ç÷°ü Á¢±Ù ½Ã½ºÅÛ ½ÃÀåÀº Á¦Ç°º°·Î ´ÙÀ½°ú °°ÀÌ ºÐ¼®µË´Ï´Ù.

  • ¸»ÃÊ »ðÀÔÇü Á᫐ Á¤¸Æ Ä«Å×ÅÍ(PICC)
  • ºñÅͳÎÇü Á᫐ Á¤¸Æ Ä«Å×ÅÍ
  • ÅͳÎÇü Ä«Å×ÅÍ
  • Æ÷Æ® Ä«Å×ÅÍ

Ç÷°ü Á¢±Ù ½Ã½ºÅÛ ½ÃÀåÀÇ ¿ëµµº° ³»¿ª

Ç×»ýÁ¦ÀÇ Á¤¸Æ³» Ä¡·á´Â ¿ëµµº° ºÎ¹® Áß ÇϳªÀÔ´Ï´Ù. º» º¸°í¼­¿¡¼­´Â Ç÷°ü Á¢±Ù ½Ã½ºÅÛ ½ÃÀåÀ» ¿ëµµº°·Î ´ÙÀ½°ú °°ÀÌ ºÐ¼®Çß½À´Ï´Ù.

  • Á¤¸Æ³» Ç×»ýÁ¦ Ä¡·á
  • ¼öÇ÷
  • Àå±â Á¤¸Æ(IV) ¿µ¾ç
  • È­Çпä¹ý
  • ±âŸ

Ç÷°ü Á¢±Ù ½Ã½ºÅÛ ½ÃÀåÀÇ ÃÖÁ¾ »ç¿ëÀÚº° ºÐ·ù

ÀÌ º¸°í¼­´Â Ç÷°ü Á¢±Ù ½Ã½ºÅÛ ½ÃÀåÀ» ¼¼ °¡Áö ÁÖ¿ä ÃÖÁ¾ »ç¿ëÀÚ¿¡ °ÉÃÄ ´ÙÀ½°ú °°ÀÌ ºÐ¼®ÇÕ´Ï´Ù.

  • º´¿ø ¹× Ŭ¸®´Ð
  • ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
  • Ä«Å×ÅÍ °Ë»ç½Ç

Ç÷°ü Á¢±Ù ½Ã½ºÅÛ ½ÃÀåÀÇ Áö¿ªº° ºÐ¼®:

ÀÌ ºÐ¼®Àº Ç÷°ü Á¢±Ù ½Ã½ºÅÛ ½ÃÀåÀ» ´ÙÀ½ Áö¿ªÀ¸·Î ³ª´©¾î ±¹°¡º° ¿¹Ãø ¹× ºÐ¼®À» ¼öÇàÇÕ´Ï´Ù.

  • ºÏ¹Ì(¹Ì±¹, ij³ª´Ù, ¸ß½ÃÄÚ)
  • ³²¹Ì(ºê¶óÁú, ¾Æ¸£ÇîÆ¼³ª, ±âŸ ³²¹Ì)
  • À¯·´(µ¶ÀÏ, ¿µ±¹, ÇÁ¶û½º, ½ºÆäÀÎ, ±âŸ À¯·´)
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«(»ç¿ìµð¾Æ¶óºñ¾Æ, UAE, ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«)
  • ¾Æ½Ã¾ÆÅÂÆò¾ç(Áß±¹, ÀϺ», Àεµ, Çѱ¹, ű¹, Àεµ³×½Ã¾Æ ¹× ±âŸ ³²¹Ì)

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå ÇöȲ

  • ½ÃÀå °³¿ä
  • ½ÃÀåÀÇ Á¤ÀÇ
  • ºÐ¼® ¹üÀ§
  • ½ÃÀå ¼¼ºÐÈ­

Á¦3Àå ºñÁî´Ï½º »óȲ

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
  • ½ÃÀå ±âȸ
  • Porter's Five Forces ºÐ¼®
  • ¾÷°è ¹ë·ùüÀÎ ºÐ¼®
  • Á¤Ã¥ ¹× ±ÔÁ¤
  • Àü·«Àû ±ÇÀå »çÇ×

Á¦4Àå ±â¼ú Àü¸Á

Á¦5Àå Ç÷°ü Á¢±Ù ½Ã½ºÅÛ ½ÃÀå : Á¦Ç°º°

  • ¼Ò°³
  • ¸»ÃÊ »ðÀÔÇü Á᫐ Á¤¸Æ Ä«Å×ÅÍ(PICC)
  • ºñÅͳÎÇü Á᫐ Á¤¸Æ Ä«Å×ÅÍ
  • ÅͳΠīÅ×ÅÍ
  • Æ÷Æ® Ä«Å×ÅÍ

Á¦6Àå Ç÷°ü Á¢±Ù ½Ã½ºÅÛ ½ÃÀå : ¿ëµµº°

  • ¼Ò°³
  • Á¤¸Æ³» Ç×»ýÁ¦ Ä¡·á
  • ¼öÇ÷
  • Àå±â Á¤¸Æ ¿µ¾ç
  • È­Çпä¹ý
  • ±âŸ

Á¦7Àå Ç÷°ü Á¢±Ù ½Ã½ºÅÛ ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

  • ¼Ò°³
  • º´¿ø ¹× Ŭ¸®´Ð
  • ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
  • Ä«Å×ÅÍ °Ë»ç½Ç

Á¦8Àå Ç÷°ü Á¢±Ù ½Ã½ºÅÛ ½ÃÀå :Áö¿ªº°

  • ¼Ò°³
  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • ³²¹Ì
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
    • ±âŸ
  • À¯·´
    • ¿µ±¹
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • ±âŸ
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
    • ±âŸ
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • ÀϺ»
    • Àεµ
    • Çѱ¹
    • ´ë¸¸
    • ű¹
    • Àεµ³×½Ã¾Æ
    • ±âŸ

Á¦9Àå °æÀï ȯ°æ°ú ºÐ¼®

  • ÁÖ¿ä ±â¾÷°ú Àü·« ºÐ¼®
  • ½ÃÀå Á¡À¯À² ºÐ¼®
  • ±â¾÷ ÇÕº´Àμö(M&A), ÇÕÀÇ, »ç¾÷ Çù·Â
  • °æÀï ´ë½Ãº¸µå

Á¦10Àå ±â¾÷ ÇÁ·ÎÆÄÀÏ

  • Edwards Lifesciences Corporation
  • Baxter International Inc.
  • Fresenius Medical Care AG & Co. KGaA
  • Becton, Dickinson and Company
  • Teleflex Incorporated
  • Medtronic PLC
  • B. Braun Melsungen AG
  • ICU Medical
  • Biomerics LLC

Á¦11Àå ºÎ·Ï

  • ÅëÈ­
  • ÀüÁ¦Á¶°Ç
  • ±âÁØ¿¬µµ°ú ¿¹Ãø¿¬µµÀÇ Å¸ÀÓ¶óÀÎ
  • ÀÌÇØ °ü°èÀÚ¿¡°Ô À־ÀÇ ÁÖ¿ä ÀÌÁ¡
  • ºÐ¼® ¹æ¹ý
  • ¾à¾î
JHS 25.04.17

The global vascular access systems market is projected to grow at a CAGR of 6.5% during the forecast period 2025 to 2030.

Venous or arterial access is obtained through vascular access systems. Vascular Access Devices or systems are medical equipment used to gain access to the bloodstream to supply medicines, administer fluids and nutritional components, and collect blood vessels and their products. These vascular access tubes are made from latex, silicone, and other substances. The procedure involves placing rigid plastic tubes into blood vessels, such as the basilic vein and subclavian vein, to perform diagnostic tests and treatments such as chemotherapy, intravenous antibiotic treatment, and intravenous feeding. It includes blood sampling, blood transfusion, fluid infusion, and central venous pressure readings. Vascular access catheter devices are also significantly used in the case of chemotherapies.

Market Trends:

  • Continuous Blood Transfer Through Vascular Access Devices: Blood is transferred to or from a person's bloodstream over an extended period using vascular access devices such as cannulae, catheters, peripherals, and ports. This method eliminates the need for repeated needle insertions, offering a less stressful and painless approach for blood draws or medication administration. The growing global prevalence of conditions like kidney failure, diabetes, and cancer, which often require blood transfer procedures, is driving demand for vascular access systems. However, challenges such as high infection risks and strict government approval processes are limiting market growth.
  • Factors Driving Market Demand: The rising incidence of diabetes, increasing road accidents, and a growing number of surgical procedures are expected to boost the demand for vascular access devices. Additionally, the shift toward advanced techniques, such as needleless drug administration, is further accelerating the adoption of these devices.
  • Comprehensive Market Analysis: The global vascular access systems market report provides an in-depth analysis of the industry, offering strategic and executive-level insights supported by data-driven forecasts. Regularly updated, the report equips decision-makers with actionable intelligence on current market trends, emerging opportunities, and competitive dynamics. It examines the demand for various vascular access products, including peripherally inserted central catheters (PICC), non-tunneled central catheters, tunneled catheters, and port catheters, across different regions. The report also evaluates the latest technological advancements in connected vascular access systems, along with key government policies, regulations, and macroeconomic factors, to present a holistic view of the market.

Some of the major players covered in this report include Edwards Lifesciences Corporation, Baxter International Inc., Fresenius Medical Care AG & Co. KGaA, Becton, Dickinson and Company, Teleflex Incorporated, Medtronic PLC, B.Braun Melsungen AG, ICU Medical, and Biomerics LLC among others.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2022 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)

Vascular Access Systems Market Segmentation:

The Vascular Access Systems Market is analysed by product into the following:

  • Peripherally Inserted Central Catheter (PICC)
  • Non-Tunneled Central Catheter
  • Tunneled Catheter
  • Port Catheter

Vascular Access Systems Market Segmentation by application:

Intravenous Antibiotic Treatment is one of the segments by application. The report analysed the vascular access systems market into different applications as below:

  • Intravenous Antibiotic Treatment
  • Blood Transfusion
  • Long-Term IV Feeding
  • Chemotherapy
  • Others

Vascular Access Systems Market Segmentation by end-user:

The report analysed the Vascular Access Systems Market across 3 major end-users as following:

  • Hospitals and Clinics
  • Ambulatory Surgical Centers
  • Catheterization Labs

Vascular Access Systems Market Segmentation by regions:

The study also analysed the Vascular Access Systems Market into the following regions, with country level forecasts and analysis as below:

  • North America (US, Canada and Mexico)
  • South America (Brazil, Argentina, and Rest of South America)
  • Europe (Germany, UK, France, Spain and Rest of Europe)
  • Middle East and Africa (Saudi Arabia, UAE and Rest of Middle East and Africa)
  • Asia Pacific (China, Japan, India, South Korea, Thailand, Indonesia, and Others)

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study

2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. VASCULAR ACCESS SYSTEMS MARKET BY PRODUCT

  • 5.1. Introduction
  • 5.2. Peripherally Inserted Central Catheter (PICC)
  • 5.3. Non-Tunneled Central Catheter
  • 5.4. Tunneled Catheter
  • 5.5. Port Catheter

6. VASCULAR ACCESS SYSTEMS MARKET BY APPLICATION

  • 6.1. Introduction
  • 6.2. Intravenous Antibiotic Treatment
  • 6.3. Blood Transfusion
  • 6.4. Long-Term IV Feeding
  • 6.5. Chemotherapy
  • 6.6. Others

7. VASCULAR ACCESS SYSTEMS MARKET BY END-USER

  • 7.1. Introduction
  • 7.2. Hospitals and Clinics
  • 7.3. Ambulatory Surgical Centers
  • 7.4. Catheterization Labs

8. VASCULAR ACCESS SYSTEMS MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. USA
    • 8.2.2. Canada
    • 8.2.3. Mexico
  • 8.3. South America
    • 8.3.1. Brazil
    • 8.3.2. Argentina
    • 8.3.3. Others
  • 8.4. Europe
    • 8.4.1. United Kingdom
    • 8.4.2. Germany
    • 8.4.3. France
    • 8.4.4. Italy
    • 8.4.5. Spain
    • 8.4.6. Others
  • 8.5. Middle East and Africa
    • 8.5.1. Saudi Arabia
    • 8.5.2. UAE
    • 8.5.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. China
    • 8.6.2. Japan
    • 8.6.3. India
    • 8.6.4. South Korea
    • 8.6.5. Taiwan
    • 8.6.6. Thailand
    • 8.6.7. Indonesia
    • 8.6.8. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Edwards Lifesciences Corporation
  • 10.2. Baxter International Inc.
  • 10.3. Fresenius Medical Care AG & Co. KGaA
  • 10.4. Becton, Dickinson and Company
  • 10.5. Teleflex Incorporated
  • 10.6. Medtronic PLC
  • 10.7. B.Braun Melsungen AG
  • 10.8. ICU Medical
  • 10.9. Biomerics LLC

11. APPENDIX

  • 11.1. Currency
  • 11.2. Assumptions
  • 11.3. Base and Forecast Years Timeline
  • 11.4. Key benefits for the stakeholders
  • 11.5. Research Methodology
  • 11.6. Abbreviations
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦